Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
16.00
-0.08 (-0.50%)
Jan 22, 2026, 1:26 PM EST - Market open
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $50.15 billion as of January 22, 2026. Its market cap has increased by 18.96% in one year.
Market Cap
50.15B
Enterprise Value
78.64B
1-Year Change
18.96%
Ranking
Category
Stock Price
$16.00
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $50.15B, a decrease of -29.57%. That is a compound annual growth rate of -2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 51.39B | 3.59% |
| Dec 31, 2025 | 49.61B | 17.75% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
| Jan 5, 2010 | 71.21B | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 55.10B |
| Haleon | 45.13B |
| Teva Pharmaceutical Industries | 36.31B |
| United Therapeutics | 20.27B |
| Viatris | 15.19B |
| Regencell Bioscience Holdings | 13.66B |
| Neurocrine Biosciences | 13.58B |
| Elanco Animal Health | 12.37B |